Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome
- 1 June 2004
- journal article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (6) , 688-690
- https://doi.org/10.1007/s00467-004-1451-y
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Pharmacokinetics of Enalapril in Children and Infants with HypertensionThe Journal of Clinical Pharmacology, 2001
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Enalapril and prednisone in children with nephrotic-range proteinuriaPediatric Nephrology, 2000
- Enalapril in paediatric patients with Alport syndrome: 2 years' experienceEuropean Journal of Pediatrics, 2000
- Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.2000
- Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-upPediatric Nephrology, 1997
- Long-term therapy with enalapril in patients with nephrotic-range proteinuriaPediatric Nephrology, 1996
- Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitusThe Journal of Pediatrics, 1990
- Oral converting enzyme inhibitor in malignant hypertension.Archives of Disease in Childhood, 1982
- MALIGNANT HYPERTENSION IN A CHILD WITH HEMOLYTIC-UREMIC SYNDROME TREATED WITH CAPTOPRILActa Paediatrica, 1981